Overview
- On June 4, 2026 Drees published an analysis of linked Assurance Maladie and INSEE data showing strong socioeconomic gradients in cancer incidence, stage at diagnosis and prognosis across France.
- The study reports that the least advantaged people face a 2.3‑times higher risk of a late‑stage diagnosis, men in the bottom 10% have a 2.2‑times higher lung cancer risk, and the bottom 10% show a 1.7‑times higher risk of cancers with poorer prognosis.
- Researchers attribute these gaps to greater exposure to risk factors such as smoking and alcohol, differences in reproductive and treatment histories, and notably lower uptake of organized screening programs.
- A pilot lung‑screening program launched in mid‑May in five regions will offer low‑dose CT scans and follow‑up to about 20,000 current and former smokers aged 50–74, with targeted outreach efforts to reach people who rarely use screening services.
- Drees and health authorities say the impact of outreach measures will be evaluated and that further Drees analysis on mortality and survival is due in autumn 2026, information that could shape future prevention and screening policies.